Filing Details
- Accession Number:
- 0001061983-17-000065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-06 20:19:01
- Reporting Period:
- 2017-11-02
- Accepted Time:
- 2017-11-06 20:19:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1674232 | Gordon Caryn Mcdowell | 280 East Grand Avenue South San Francisco CA 94080 | Gc & Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-02 | 77 | $6.67 | 17,982 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-02 | 2,460 | $12.90 | 15,522 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-11-02 | 653 | $6.67 | 16,175 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-02 | 1,800 | $13.00 | 14,375 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-11-02 | 625 | $6.37 | 15,000 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2017-11-02 | 625 | $0.00 | 625 | $6.37 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2017-11-02 | 653 | $0.00 | 653 | $6.67 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-11-02 | 77 | $0.00 | 77 | $6.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,875 | 2016-05-29 | 2025-05-29 | No | 4 | M | Direct |
19,343 | 2016-03-23 | 2026-02-23 | No | 4 | M | Direct |
1,075 | 2016-03-23 | 2026-02-23 | No | 4 | M | Direct |
Footnotes
- The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.